The Paradox Powering IBM's Stock: Record Chip Density Meets Stagnant Consulting Growth
26.06.2026 - 16:17:32 | boerse-global.de
IBM is telling two stories at once, and investors are struggling to decide which one to believe. On one hand, the company just unveiled the world’s first sub-nanometre chip — a 0.7nm design that squeezes 100 billion transistors onto an area the size of a fingernail. On the other, its consulting business grew at just 1% last quarter, and the shares are nursing a year-to-date decline of nearly 9%.
The disconnect has left the stock trading at €227.15, more than 20% below the record high of €292.85 it touched in early June. That peak was short-lived; a profit warning from Accenture on June 18 sent the entire IT services sector into a tailspin, and IBM’s equity has yet to fully recover despite a subsequent partnership with ServiceNow and fresh AI security offerings.
The NanoStack breakthrough
The chip milestone, announced on June 25, is built around a technology IBM calls “NanoStack”. By stacking transistors vertically in a three-dimensional architecture, the company has doubled transistor density compared with current standards. The new design delivers a 50% performance boost or, alternatively, a 70% reduction in energy consumption — a potential game-changer for training large language models, which might soon take only two weeks instead of months.
Industry experts see the breakthrough as an extension of Moore’s Law by at least another decade. But IBM has no intention of manufacturing these chips at scale. The business model relies on licensing the technology to partners such as Samsung and Rapidus, with commercial production not expected until the early 2030s. For a market that demands quarterly results, a five-year wait is an eternity.
Should investors sell immediately? Or is it worth buying IBM?
The $12.5bn backlog that isn’t billing yet
Investors are more focused on the here and now. IBM’s generative AI order backlog has swelled to €12.5 billion, yet revenue from its largest segment — consulting — barely budged in the first quarter, rising just 1% at constant currency. The big question is whether that backlog will eventually translate into billable work or whether AI automation will cannibalise the legacy services that have long fuelled IBM’s income.
A company-commissioned study adds to the caution: 91% of surveyed board members admit they do not fully understand their own AI dependencies. That lack of readiness on the client side is lengthening the monetisation cycle, meaning IBM could keep announcing technological triumphs while its consulting arm trundles along in low single-digit growth.
Technical crossroads
From a technical perspective, the stock is in a tight range. It recently stabilised above the 50-day moving average of €217.50 and the 100-day average of €217.07, having bounced more than 25% from the 52-week low of €181.32 set in mid-May. The relative strength index sits at 49.2, neutral territory. But the real test lies at the 200-day moving average of €235.79, which the shares currently trade about 3.7% below.
Analysts see a consensus price target of €258.85, implying roughly 14% upside — provided that the ServiceNow alliance and similar partnerships start generating volume in high-margin AI automation. Yet that target hinges on a clear breakout above the 200-day line. Failing that, a slide back under €217.50 would darken the technical picture and could trigger another attempt on the 52-week low.
IBM at a turning point? This analysis reveals what investors need to know now.
The July catalyst
The next concrete marker is the second-quarter earnings report, expected in mid-July. That print will be the first hard data point showing whether the €12.5 billion AI order book is finally flowing through to the profit-and-loss statement. If it is, the stock could reclaim the €236 level and begin a march toward the analyst target. If not, the gap between IBM’s technology prowess and its near-term revenue reality will only widen.
For now, the market is reserving judgment — impressed by the NanoStack marvel but unwilling to reward it until the consulting engine shows it can convert innovation into growth.
Ad
IBM Stock: New Analysis - 26 June
Fresh IBM information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
